Cargando…
Botulinum Neurotoxin Type a Injection Combined with Absorbable Punctal Plug Insertion: An Effective Therapy for Blepharospasm Patients with Dry Eye
Blepharospasm patients often have dry eye manifestations. Botulinum neurotoxin type A (BoNT-A) injection has been the main management for blepharospasm and absorbable punctal plug (APP) insertion is shown to be effective in the treatment of dry eye. However, there have been no studies investigating...
Autores principales: | Ndikumukiza, Malachie, Xiao, Yu-Ting, Ye, You-Fan, Wang, Jia-Song, Peng, Xi, Xie, Hua-Tao, Zhang, Ming-Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918122/ https://www.ncbi.nlm.nih.gov/pubmed/36769526 http://dx.doi.org/10.3390/jcm12030877 |
Ejemplares similares
-
Botulinum neurotoxin type A versus punctal plug insertion in the management of dry eye disease
por: Bukhari, Amal A.
Publicado: (2014) -
Microbiologic Analysis of Removed Silicone Punctal Plugs in Dry Eye Patients
por: Jung, Il, et al.
Publicado: (2022) -
Comparison Between Botulinum Toxin A Injection and Lacrimal Punctal Plugs for the Control of Post-LASIK Dry Eye Manifestations: A Prospective Study
por: Fouda, Sameh M., et al.
Publicado: (2017) -
Changes of Dry Eye Parameters Especially Meibomian Gland Functions After Punctal Plugs Insertion in Aqueous-Deficient Dry Eye Patients
por: Liu, Tingting, et al.
Publicado: (2022) -
Clinical evaluation of the therapeutic effects of atelocollagen absorbable punctal plugs
por: Hirai, Kaori, et al.
Publicado: (2012)